Applied Sterilization Technologies

Steris (NYSE: STE) + today reported first-quarter results that exceeded Wall Street’s expectations while upping guidance for the year ahead due to a recently announced acquisition.

The Dublin, Ireland-based provider of sterilization services and other infection prevention tech posted profits of $123.6 million in the quarter ended June 30, 2023. That amounts to $1.25 per share on sales of $1.28 billion.

Steris reported top- and bottom-line gains of 11%.

Adjusted to exclude one-time items, earnings per share (EPS) totaled $2.00. Wall Street analysts were expecting adjusted EPS of $1.87 on sales of $1.21 billion.

“We are pleased to start the year with strong performance,” Steris President and CEO Dan Carestio said in a news release. “Our first quarter results benefited from continued improvement in procedure volumes and supply chain challenges easing. In addition to those factors, our ability to reduce…

Steris (NYSE:STE) today reported fourth-quarter results that exceeded Wall Street’s expectations while upping guidance for the year ahead.

Shares of STE climbed 4% t0 $197 apiece in after-hours trading. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was flat on the day.

The Dublin, Ireland-based provider of sterilization services and other infection prevention tech posted profits of $187.2 million in the quarter ended March 31, 2023. That amounts to $1.89 per share on sales of $1.38 billion.

Steris recorded a 259% bottom-line gain on sales growth of 14.3%.

Adjusted to exclude one-time items, earnings per share (EPS) totaled $2.30. Wall Street analysts were expecting adjusted EPS of $2.15 on sales of $1.27 billion.

“We are pleased to end the year with strong performance,” Steris President and CEO Dan Carestio said in a news release. “Our teams worked diligently to meet customer de…